Welcome
Tahoe Forest Cancer Center, located in Truckee California, is led by Medical Director Laurence Heifetz, MD, FACP and Medical Oncologist Hematologist Ahrin Koppel, MD. The mission of the Tahoe Forest Cancer Center is to provide the highest quality cancer treatment and care to our patients using the most appropriate and current cancer therapies available in an honest, supportive, compassionate and respectful manner.
Latest Cancer News
FDA Cautions Against Long-Term Use of Bisphosphonates
(05-21-2012)
The U.S. Food and Drug Administration (FDA) has performed a systematic review of the long-term safety and efficacy of bisphosphonates and has recommended caution and updated labeling, but stopped short... Continue Reading
Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies... Continue Reading
Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies... Continue Reading
The U.S. Food and Drug Administration (FDA) has performed a systematic review of the long-term safety and efficacy of bisphosphonates and has recommended caution and updated labeling, but stopped short... Continue Reading
Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies... Continue Reading
Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies... Continue Reading
